These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7784418)

  • 21. [Mifepristone--a controversial drug with great potential].
    Bjørge L; Iversen OE
    Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3286-91. PubMed ID: 11826459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 11' imidazolyl antiprogestins and mesoprogestins.
    Nickisch K; Elger W; Santhamma B; Garfield R; Killeen Z; Amelkina O; Schneider B; Meister R
    Steroids; 2014 Dec; 92():45-55. PubMed ID: 25174783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiprogesterone RU 486--a drug for non-surgical abortion.
    Heikinheimo O; Ylikorkala O; Lähteenmäki P
    Ann Med; 1990 Apr; 22(2):75-84. PubMed ID: 2193662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [RU-486: clinical application in gynecology].
    Menashe Y; Shalev J; Serr DM
    Harefuah; 1989 May; 116(10):532-5. PubMed ID: 2676767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New indications for mifepristone (RU 486), an antiprogesterone].
    Presl J
    Cesk Gynekol; 1993 Oct; 58(5):255-6. PubMed ID: 8221923
    [No Abstract]   [Full Text] [Related]  

  • 26. Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancy.
    Perusquía M; Espinoza J; Navarrete E
    Steroids; 2009 Oct; 74(10-11):825-31. PubMed ID: 19464306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RU 486: how abortion politics have impacted on a potentially useful drug of broad medical application.
    Regelson W
    Perspect Biol Med; 1992; 35(3):330-8. PubMed ID: 1501996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RU 486.
    Ulmann A; Teutsch G; Philibert D
    Sci Am; 1990 Jun; 262(6):42-8. PubMed ID: 2343294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical use of RU 486 (Mefipristone).
    Herrmann W
    Res Reprod; 1989 Oct; 21(4):3. PubMed ID: 12282921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone antagonist RU 486 accommodates but does not induce labour and delivery in primates.
    Wolf JP; Simon J; Itskovitz J; Sinosich MJ; Ulmann A; Baulieu EE; Hodgen GD
    Hum Reprod; 1993 May; 8(5):759-63. PubMed ID: 8314974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications.
    Baulieu EE
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):873-91. PubMed ID: 1778181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigestagens].
    van Uem JF; Hodgen GD
    Geburtshilfe Frauenheilkd; 1988 Dec; 48(12):829-34. PubMed ID: 3069562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mifepristone: current knowledge and emerging prospects.
    Kakade AS; Kulkarni YS
    J Indian Med Assoc; 2014 Jan; 112(1):36-40. PubMed ID: 25935948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women.
    Spitz IM; Shoupe D; Sitruk-Ware R; Mishell DR
    J Reprod Fertil Suppl; 1989; 37():253-60. PubMed ID: 2681741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RU 486 (mifepristone): from clinical trials to the perspectives for clinical use.
    Elia D; Ulmann A
    Contracept Fertil Sex (Paris); 1986 Dec; 14(12):1099-103. PubMed ID: 12314688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new antiprogestational compound, mifepristone (RU-486)].
    Parisi C; Steffe M
    Patol Clin Ostet Ginecol; 1988; 16(4):291-4. PubMed ID: 12345008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RU486 (mifepristone): mechanisms of action and clinical uses.
    Cadepond F; Ulmann A; Baulieu EE
    Annu Rev Med; 1997; 48():129-56. PubMed ID: 9046951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifepristone (RU 486) in Cushing's syndrome.
    Johanssen S; Allolio B
    Eur J Endocrinol; 2007 Nov; 157(5):561-9. PubMed ID: 17984235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.